The LALF 32-51 peptide as component of HPV therapeutic vaccine circumvents the alum-mediated inhibition of IL-12 and promotes a Th1 response-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

ID:am030003M003513368desz95📫 -页
The LALF 32-51 peptide as component of HPV therapeutic vaccine circumvents the alum-mediated inhibition of IL-12 and promotes a Th1 response-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
⚠ 举报QQ邮箱: 361755509@qq.com⚠ 版权申诉QQ邮箱: 361755509@qq.com

内容摘要

The LALF 32-51 peptide as component of HPV therapeutic vaccine circumvents the alum-mediated inhibition of IL-12 and promotes a Th1 response-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

海外数据平台所有内容均是公开网络、AI代理代查、客户上传分享、合作方,仅供网友学习交流,请勿商用!

海外数据(小程序)

微信小程序

请使用微信扫码打开小程序